Cliniq Flo
Cliniq Flo
Clinical Insights
13 min read
June 21, 2026

COPD, Asthma, and Respiratory Disease OPD Management: A Guide for Indian Clinic Doctors

Evidence-based protocols for managing COPD, asthma, TB screening, and breathlessness in Indian OPD — including inhaler technique assessment, exacerbation management, and pulmonary referral criteria.

COPD management clinic Indiaasthma OPD treatment Indiabreathlessness diagnosis Indian doctorsTB screening clinic India
CF

Cliniq Flo Editorial Team

Clinic Management Experts · India

Want to implement this in your clinic?

Cliniq Flo covers everything in this guide — ABDM, GST billing, OPD management, lab, pharmacy. Book a free 30-minute demo.

Book Free Demo
37MIndians with asthma
55MIndians with COPD
2.8Mnew TB cases in India annually (27% of global burden)
70%of asthma patients have poor inhaler technique

Respiratory disease in India carries a unique burden: India has the world's highest COPD mortality, a massive asthma population, and 27% of the global tuberculosis burden. Every clinic doctor in India is, by necessity, a front-line respiratory physician.

Approach to Breathlessness in OPD

Breathlessness is never just "breathlessness" — the differential spans cardiac, respiratory, haematological, and metabolic causes. Structured assessment prevents missing dangerous diagnoses:

  • Onset: Acute (minutes) → think PE, pneumothorax, acute LVF, anaphylaxis. Subacute (days) → pneumonia, AECOPD, pleural effusion. Chronic/progressive → COPD, heart failure, ILD, anaemia
  • Position: Orthopnoea (worse lying flat) → heart failure. Platypnoea (worse sitting up) → hepatopulmonary syndrome
  • Associated symptoms: Wheeze → asthma/COPD. Cough + fever → infection. Chest pain → PE/pneumonia/pneumothorax. Haemoptysis → TB/malignancy/PE
  • Examination essentials: SpO₂ (every breathless patient), RR (most neglected vital sign), percussion (dull = effusion/consolidation; hyperresonant = pneumothorax), auscultation
🚨
SpO₂ <92% = immediate action required
SpO₂ <92% on room air is a medical emergency. Give supplemental oxygen, call 108, and prepare for transfer. Do not discharge a breathless patient without checking SpO₂. In COPD patients, target SpO₂ 88–92% (not 98–100%) — high-flow O₂ can suppress hypoxic drive and cause CO₂ retention.

Asthma: Diagnosis and Step-Up Therapy

Diagnosis

Asthma is a clinical diagnosis. Key features: episodic wheeze, breathlessness, chest tightness, cough (especially nocturnal) — variable and reversible. Confirm with spirometry if available: FEV1/FVC <0.7 with ≥12% and 200ml improvement post-bronchodilator.

In Indian children, be aware that GORD, rhinitis, and post-nasal drip are common asthma mimics. Treat comorbidities alongside asthma.

GINA 2024 Step-Up Therapy

1
Step 1: Symptoms ≤2 days/week, no night wakings
As-needed low-dose ICS-formoterol (Budesonide-Formoterol 200/6 mcg) used only when symptomatic. This replaces SABA monotherapy — GINA 2019+ no longer recommends SABA-only for any step.
2
Step 2: Symptoms >2 days/week or any night waking
Low-dose ICS daily (Budesonide 200mcg BD or Fluticasone 100mcg BD) + as-needed SABA. Alternatively: low-dose ICS-formoterol as both maintenance and reliever (MART regimen).
3
Step 3: Not controlled on Step 2
Medium-dose ICS + LABA (Budesonide 400mcg + Formoterol BD). Add montelukast if allergic rhinitis is comorbid. Review inhaler technique and adherence before stepping up.
4
Step 4–5: Severe/uncontrolled asthma
High-dose ICS-LABA + LAMA (Tiotropium). If still uncontrolled: refer to pulmonologist for biologic therapy (anti-IgE, anti-IL-5). Oral steroids only as last resort for long-term control.

COPD: Diagnosis, Staging, and Management

Diagnosis

Suspect COPD in any patient >40 with: chronic productive cough, exertional breathlessness, or history of smoking / biomass fuel exposure (chulha cooking — a major Indian COPD cause, especially in women). Confirm with post-bronchodilator spirometry: FEV1/FVC <0.7.

GOLD Staging and Treatment

GOLD Stage FEV1 % Predicted Initial Treatment
GOLD 1 (Mild)≥80%SABA PRN + smoking cessation
GOLD 2 (Moderate)50–79%LAMA (Tiotropium 18mcg OD)
GOLD 3 (Severe)30–49%LAMA + LABA, consider ICS if frequent exacerbations
GOLD 4 (Very Severe)<30%Triple therapy (ICS+LABA+LAMA) + pulmonology co-management

All COPD patients regardless of stage: influenza vaccine annually, pneumococcal vaccine (PCV13 + PPSV23), pulmonary rehabilitation referral if available, smoking cessation counselling every visit.

Acute Exacerbation Management in OPD

AECOPD: acute worsening of respiratory symptoms beyond day-to-day variation. Decide: OPD treatment vs hospitalise?

Treat in OPD if all of: SpO₂ ≥92%, able to speak in full sentences, no accessory muscle use, no altered consciousness, good home support

Hospitalise immediately if any of: SpO₂ <90%, RR >30, HR >110, altered consciousness, inability to manage at home, failure to improve with initial treatment

OPD exacerbation protocol:

  1. Salbutamol 2.5mg nebulisation, repeat at 20 minutes if needed
  2. Ipratropium 500mcg nebulisation combined with salbutamol
  3. Prednisolone 40mg OD for 5 days
  4. Antibiotics if purulent sputum: Amoxicillin-clavulanate 625mg TDS or Doxycycline 100mg BD for 5 days
  5. Reassess SpO₂ 1 hour after nebulisation before discharge

Inhaler Technique: The Most Overlooked Treatment Failure

Studies show 70–80% of patients use inhalers incorrectly. Before escalating treatment, always assess technique:

pMDI (pressurised metered-dose inhaler) — common errors in India:

  • Not shaking before use
  • Inhaling too fast (should be slow, over 3–5 seconds)
  • Not holding breath for 10 seconds after inhalation
  • Firing the inhaler before starting to inhale

A spacer device eliminates most pMDI technique errors and is recommended for all patients, especially children and elderly. A 500ml plastic bottle with a hole cut in the cap works as a spacer in resource-limited settings.

TB Screening in OPD: Every Cough for 2 Weeks

India has 2.8 million new TB cases annually — 27% of the global burden. Every clinic doctor is on the front line of detection.

🫁
Universal TB screening in OPD
Every patient with cough ≥2 weeks: ask about fever, night sweats, weight loss. Sputum CBNAAT (GeneXpert) is the first-line test — more sensitive than smear microscopy and gives rifampicin resistance status simultaneously. CBNAAT is available free at government labs under NTEP. Order it, don't refer — you lose the patient in the referral chain.

TB treatment: Do not start treatment without microbiological confirmation if possible. Presumptive TB (CBNAAT negative but strong clinical suspicion): discuss with pulmonologist or DTCO. Nikshay portal: all diagnosed TB patients must be registered. Government provides free ATT (HRZE for 2 months, HR for 4 months) and monthly ₹500 nutritional support (Nikshay Poshan Yojana).

Community-Acquired Pneumonia in OPD

Use the CRB-65 score to decide OPD treatment vs admission:

  • Confusion: new onset
  • Respiratory rate ≥30/min
  • BP <90 systolic or <60 diastolic
  • Age ≥65

Score 0: OPD treatment. Score 1–2: Consider admission. Score ≥3: Hospitalise urgently.

OPD CAP treatment: Amoxicillin 500mg–1g TDS for 5 days (first choice). If atypical features (dry cough, bilateral infiltrates, younger patient): add Azithromycin 500mg OD for 3 days. Confirm improvement at 48 hours — failure to improve demands hospitalisation.

Keep respiratory patients on structured follow-up — SpO₂, symptom diary, inhaler reviews. CliniqFlo's appointment system helps schedule 3-month COPD reviews automatically →

Start Using Cliniq Flo in Your Clinic Today

ABDM-ready · GST-compliant · Built for India · Free onboarding · 500+ clinics trust us

Tagged

COPD management clinic Indiaasthma OPD treatment Indiabreathlessness diagnosis Indian doctorsTB screening clinic Indiainhaler technique India